proximicin B

antineoplastic agent isolated from Verrucosispora; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	T-Cell Leukemia (Leukemia, T Cell) 03/15/2012 - "Proximicin B induced apoptosis in both Hodgkin's lymphoma and T-cell leukemia cell lines and proximicin C exhibited significantly high cytotoxicity against glioblastoma and breast carcinoma cells. "
2.	Tuberculosis (Tuberculoses) 09/01/2016 - "Proximicin B (4) showed significant anti-MRSA (MIC = 3.125 μg/mL), anti-BCG (MIC = 6.25 μg/mL), and anti-tuberculosis (TB) (MIC = 25 μg/mL) activities. "
3.	Hodgkin Disease (Hodgkin's Disease) 03/15/2012 - "Proximicin B induced apoptosis in both Hodgkin's lymphoma and T-cell leukemia cell lines and proximicin C exhibited significantly high cytotoxicity against glioblastoma and breast carcinoma cells. "
4.	Glioblastoma (Glioblastoma Multiforme) 03/15/2012 - "Proximicin B induced apoptosis in both Hodgkin's lymphoma and T-cell leukemia cell lines and proximicin C exhibited significantly high cytotoxicity against glioblastoma and breast carcinoma cells. "
5.	Breast Neoplasms (Breast Cancer) 03/15/2012 - "Proximicin B induced apoptosis in both Hodgkin's lymphoma and T-cell leukemia cell lines and proximicin C exhibited significantly high cytotoxicity against glioblastoma and breast carcinoma cells. "

1.	proximicin C